Clinical Performance of QIAstat-Dx® Gastrointestinal Panel 2

NCT06745414 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-01-17

No results posted yet for this study

Summary

Performance evaluation of QIAstat-Dx® GI2 Panel using the QIAstat-Dx® Analyzer to demonstrate that the QIAstat-Dx® GI2 Panel achieves its intended performance during normal conditions of use by the intended user in the intended environment

Conditions

  • Gastrointestinal Infection

Sponsors & Collaborators

  • QIAGEN Gaithersburg, Inc

    lead INDUSTRY

Principal Investigators

  • Sarah Johnson · Qiagen Manchester Limited

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-14
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06745414 on ClinicalTrials.gov